SCHEMBL26101314

SCHEMBL26101314

CCN1CCC(COc2cc3ncnc(-c4ccc(C(C(N)=O)c5ccc(C(F)(F)F)nc5)cc4)c3cc2OC)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIT P10721 6/20 0.42
▸ EGFR P00533 5/20 0.40
▸ PDGFRB P09619 3/20 0.39
▸ P2RX7 Q99572 1/20 0.39
▸ KDR P35968 4/20 0.38
▸ SLC2A1 P11166 1/20 0.38
▸ ENPP1 P22413 2/20 0.38
▸ MAPK7 Q13164 1/20 0.38
▸ RET P07949 2/20 0.38
▸ KIF5B P33176 2/20 0.38
▸ FGFR1 P11362 2/20 0.37
▸ FLT1 P17948 2/20 0.37
▸ FLT4 P35916 2/20 0.37
▸ BMPR1B O00238 1/20 0.37
▸ PLK4 O00444 1/20 0.37
▸ CIT O14578 1/20 0.37
▸ GAK O14976 1/20 0.37
▸ EPHB6 O15197 1/20 0.37
▸ RIPK2 O43353 1/20 0.37
▸ ROCK2 O75116 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26102560 0.93 EGFR (0.48) KITEGFRPDGFRBKDRRET
SCHEMBL26099862 0.93 MAPK7 (0.45) KITEGFRPDGFRBKDRSLC2A1
SCHEMBL30891778 0.93 MAPK7 (0.45) KITEGFRPDGFRBKDRSLC2A1
SCHEMBL26102638 0.93 KDR (0.41) KITEGFRPDGFRBP2RX7KDR
SCHEMBL26103289 0.93 KIT (0.43) KITEGFRPDGFRBP2RX7KDR
SCHEMBL26102536 0.92 MAPK7 (0.41) KITEGFRPDGFRBP2RX7KDR
SCHEMBL26103463 0.89 MAPK7 (0.44) KITEGFRKDRSLC2A1ENPP1
SCHEMBL26103479 0.89 EGFR (0.44) KITEGFRP2RX7KDRENPP1
SCHEMBL26099835 0.88 KDR (0.40) KITEGFRPDGFRBKDRENPP1
SCHEMBL26102800 0.88 HTR1A (0.45) KITEGFRKDRSLC2A1ENPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023075529-A1 QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF 보로노이바이오 주식회사 2023-05-04 — — WO disclosed
Send feedback